| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Century Therapeutics (NASDAQ:IPSC) reported its Q3 earnings results on Thursday, November 9, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Century Therapeutics missed estimated earnings by 7.84%, reporting an EPS of $-0.55 versus an estimate of $-0.51.
Revenue was down $2.08 million from the same period last year.
Last quarter the company missed on EPS by $0.02 which was followed by a 4.91% drop in the share price the next day.
Here's a look at Century Therapeutics's past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.54 | -0.52 | -0.59 | -0.59 |
| EPS Actual | -0.56 | -0.53 | -0.55 | -0.53 |
| Revenue Estimate | 1.14M | 1.31M | 1.97M | 1.13M |
| Revenue Actual | 99K | 1.72M | 521K | 2.22M |
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Century Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: IPSC
